Robert Friedman specializes in defending leading companies in product liability and mass tort cases. Robert's diverse litigation and trial practice focuses on the pharmaceutical, energy and automotive industries.

Robert represents pharmaceutical, automotive and energy companies in high-exposure cases, often including “bet-the-company” litigation involving flagship brands. He helps clients to respond to congressional and other government inquiries, and actively litigates personal injury cases in the country’s most challenging jurisdictions.

For more than 15 years, Robert has represented GlaxoSmithKline in conjunction with its antidepressant medication, Paxil, and participated in numerous successful trials. He is also lead counsel for Shell Oil Company in suits and government investigations in more than 20 states, most brought by State AGs, over Shell’s recovery of money from state trust funds for cleaning up environmental contamination at its former service stations.

Robert has particular knowledge of electronic discovery. As a member of our E-Discovery Practice Group, he regularly advises clients on E-Discovery issues, including both litigation preparedness and discovery strategy in active litigation.

Robert speaks and writes frequently on a variety of litigation-related topics. He has been listed by Law 360 as a “Rising Star” among America’s top legal talent under age 40 and was identified as a "Rising Star" by Product Liability 360.

Back to Page